BRITTNEY ATHERAS: Open Payments
NPI 1992339634 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 54 payments from 30 companies in 2025. Trend: 2023 $2,555 · 2024 $1,529 · 2025 $1,110
Food & beverage: $1,088Education: $23
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $116 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Genentech USA, Inc. | 3 | $57 |
| PFIZER INC. | 3 | $56 |
| Geron Corporation | 3 | $52 |
| Incyte Corporation | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Genmab U.S., Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: RYBREVANT, KEYTRUDA, XTANDI, RYTELO, OPDIVO, Nubeqa, Enhertu, REBLOZYL.
Industry payments across NJ — which companies pay providers there.
